LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Legal & Regulatory and Reimbursement/510(k) Clearance Expands Cadence and Ankle System Indications
Legal & Regulatory and Reimbursement

510(k) Clearance Expands Cadence and Ankle System Indications

September 25, 2024 1 min read Premium comments

Advertisement

510(k) Clearance Expands Cadence and Ankle System Indications
Cadence Optech Talus Guide / Source: Smith+Nephew
Smith NephewSecondary#3dsystems#cadenceankelpsisystem#saltotalarispsisystem#vantagepsisystem

The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the combined use of two surgical planning and patient specific instrument sets for ankle surgery.

3D Systems, Inc., based in Littleton, Colorado, submitted the devices for 510(k) clearance. The ankle arthroplasty implantation systems were cleared for use with certain Smith+Nephew systems.

According to the FDA’s summary document, the Cadence Ankle PSI System is “intended to be used as patient specific surgical planning and instrumentation to assist in the positioning of total ankle replacement components intraoperatively, and in guiding bone cutting.”

Furthermore, the Cadence Ankle PSI System is “intended for use with Smith+Nephew’s Cadence Total Ankle System and its cleared indications for use.” The combination of the surgical guides and instruments “facilitate the positioning of Cadence Total Ankle Prostheses.”

Moving to the Salto Talaris PSI System, according to the FDA’s summary document, it is “intended to be used as patient specific surgical planning and instrumentation to assist in the positioning of total ankle replacement components intraoperatively, and in guiding bone cutting.”

The Salto Talaris PSI System is also “intended for use with Smith+Nephew’s Salto Talaris Total Ankle System and its cleared indications for use.” When used in combination, the surgical guides and total ankle system, “facilitate the positioning of Salto Talaris Total Ankle Prostheses”

In order to qualify for the shorter and earlier 510(k) clearance medical devices must be substantially equivalent to a predicate device. Here, both systems have the same indications for use as the predicate device, Vantage® PSI System, an ankle arthroplasty implantation system. According to FDA document, the only change is “the orthopedic implant that the patient-specific instrumentation is guiding.”

Mark McMahan, the vice president of marketing, global orthopaedics at Smith+Nephew, expressed excitement about the partnership, saying, “We are excited to partner with 3D Systems and unveil our new TOTAL ANKLE Patient-Matched Guides for total ankle replacement—a breakthrough to help transform the way healthcare professionals approach surgical precision and improved patient outcomes.”

McMahan continued, “This advanced system is designed to offer unparalleled efficiency and accuracy, ultimately enhancing the overall experience for both surgeons and patients.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy